Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
- PMID: 36947108
- PMCID: PMC10032659
- DOI: 10.7554/eLife.86002
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
Abstract
COVID-19, with persistent and new onset of symptoms such as fatigue, post-exertional malaise, and cognitive dysfunction that last for months and impact everyday functioning, is referred to as Long COVID under the general category of post-acute sequelae of SARS-CoV-2 infection (PASC). PASC is highly heterogenous and may be associated with multisystem tissue damage/dysfunction including acute encephalitis, cardiopulmonary syndromes, fibrosis, hepatobiliary damages, gastrointestinal dysregulation, myocardial infarction, neuromuscular syndromes, neuropsychiatric disorders, pulmonary damage, renal failure, stroke, and vascular endothelial dysregulation. A better understanding of the pathophysiologic mechanisms underlying PASC is essential to guide prevention and treatment. This review addresses potential mechanisms and hypotheses that connect SARS-CoV-2 infection to long-term health consequences. Comparisons between PASC and other virus-initiated chronic syndromes such as myalgic encephalomyelitis/chronic fatigue syndrome and postural orthostatic tachycardia syndrome will be addressed. Aligning symptoms with other chronic syndromes and identifying potentially regulated common underlining pathways may be necessary for understanding the true nature of PASC. The discussed contributors to PASC symptoms include sequelae from acute SARS-CoV-2 injury to one or more organs, persistent reservoirs of the replicating virus or its remnants in several tissues, re-activation of latent pathogens such as Epstein-Barr and herpes viruses in COVID-19 immune-dysregulated tissue environment, SARS-CoV-2 interactions with host microbiome/virome communities, clotting/coagulation dysregulation, dysfunctional brainstem/vagus nerve signaling, dysautonomia or autonomic dysfunction, ongoing activity of primed immune cells, and autoimmunity due to molecular mimicry between pathogen and host proteins. The individualized nature of PASC symptoms suggests that different therapeutic approaches may be required to best manage specific patients.
Keywords: Long COVID; PASC; angiotensin-converting enzyme; epidemiology; global health; immunology; inflammation; pathobiological mechanisms; pathophysiological mechanisms; post-viral syndromes; tissue damage.
Conflict of interest statement
ZS, CG, TC, TH, WR No competing interests declared
Figures
Similar articles
-
Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.Front Microbiol. 2021 Jun 23;12:698169. doi: 10.3389/fmicb.2021.698169. eCollection 2021. Front Microbiol. 2021. PMID: 34248921 Free PMC article. Review.
-
Long COVID in pediatrics-epidemiology, diagnosis, and management.Eur J Pediatr. 2024 Apr;183(4):1543-1553. doi: 10.1007/s00431-023-05360-y. Epub 2024 Jan 27. Eur J Pediatr. 2024. PMID: 38279014 Free PMC article. Review.
-
The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.Curr Neurol Neurosci Rep. 2021 Jun 28;21(9):44. doi: 10.1007/s11910-021-01130-1. Curr Neurol Neurosci Rep. 2021. PMID: 34181102 Free PMC article. Review.
-
Long Covid.Prog Mol Biol Transl Sci. 2024;202:113-125. doi: 10.1016/bs.pmbts.2023.11.002. Epub 2024 Jan 3. Prog Mol Biol Transl Sci. 2024. PMID: 38237983
-
A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.BMC Infect Dis. 2021 Jul 13;21(1):677. doi: 10.1186/s12879-021-06359-2. BMC Infect Dis. 2021. PMID: 34256735 Free PMC article.
Cited by
-
Personalised Health Behaviour Support Programme in Adults With Post-COVID Syndrome: A Randomised, Controlled Pilot Feasibility Trial.Health Expect. 2024 Oct;27(5):e70079. doi: 10.1111/hex.70079. Health Expect. 2024. PMID: 39462879 Free PMC article. Clinical Trial.
-
Antigen-specific T cell responses in SARS-CoV-2 mRNA-vaccinated children.Cell Rep Med. 2023 Dec 19;4(12):101298. doi: 10.1016/j.xcrm.2023.101298. Epub 2023 Nov 27. Cell Rep Med. 2023. PMID: 38016480 Free PMC article.
-
Chronic lung inflammation and CK14+ basal cell proliferation induce persistent alveolar-bronchiolization in SARS-CoV-2-infected hamsters.EBioMedicine. 2024 Oct;108:105363. doi: 10.1016/j.ebiom.2024.105363. Epub 2024 Sep 25. EBioMedicine. 2024. PMID: 39326207 Free PMC article.
-
The importance of estimating prevalence of ME/CFS in future epidemiological studies of long COVID.Front Public Health. 2023 Nov 3;11:1275827. doi: 10.3389/fpubh.2023.1275827. eCollection 2023. Front Public Health. 2023. PMID: 38026427 Free PMC article. No abstract available.
-
Quantifying the impact of post-acute sequelae of coronavirus on the cardiopulmonary endurance of athletes.Pulm Circ. 2024 Jul 17;14(3):e12413. doi: 10.1002/pul2.12413. eCollection 2024 Jul. Pulm Circ. 2024. PMID: 39022309 Free PMC article.
References
-
- Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. New England Journal of Medicine. 2020;383:120–128. doi: 10.1056/NEJMoa2015432. - DOI - PMC - PubMed
-
- Aird WC. Phenotypic heterogeneity of the endothelium: II. representative vascular beds. Circulation Research. 2007;100:174–190. doi: 10.1161/01.RES.0000255690.03436.ae. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
